Crocs director receives 1,252-share stock grant

KAPLAN BETH J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

KAPLAN BETH J reported acquisition or exercise transactions in this Form 4 filing.

Crocs, Inc. director Beth J. Kaplan received an equity award of 1,252 shares of common stock as part of her annual compensation. The shares were granted at no cash cost to her and bring her directly held stake to 14,374 shares. The footnote explains this is the regular annual common stock grant to non-employee directors under the company’s Board of Directors Compensation Plan, indicating a routine, compensation-related transaction rather than an open-market trade.

Insights

Equity compensation analyst

Routine director stock grant with no open-market trading.

Director Beth J. Kaplan received 1,252 shares of Crocs, Inc. common stock as a grant under the Board’s compensation plan. The grant price is listed as $0.0000 per share, signaling standard equity compensation rather than a purchase.

The filing shows her directly held position rising to 14,374 shares after the award. There are no derivative holdings reported and no sales, exercises, or tax withholdings, so this looks like a straightforward, recurring element of non-employee director pay rather than a signal about her view of the stock.

Insider Trade Summary

Grant/Award: 1,252 shares

Grant/Award 1 txn

Insider KAPLAN BETH J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,252	$0.00	$0.00

Holdings After Transaction: Common Stock — 14,374 shares (Direct)

Footnotes (1)

1. F1. Represents the annual common stock grant to non-employee directors pursuant to the issuer's Board of Directors Compensation Plan.

Key Figures

Shares granted: 1,252 shares Grant price: $0.0000 per share Shares held after: 14,374 shares

3 metrics

Shares granted 1,252 shares Annual common stock grant to non-employee director

Grant price $0.0000 per share Equity award, not open-market purchase

Shares held after 14,374 shares Beth J. Kaplan direct ownership following grant

Key Terms

annual common stock grant, non-employee directors, Board of Directors Compensation Plan, Form 4

4 terms

annual common stock grant financial

"Represents the annual common stock grant to non-employee directors"

non-employee directors financial

"annual common stock grant to non-employee directors pursuant to the issuer's Board"

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

Board of Directors Compensation Plan financial

"pursuant to the issuer's Board of Directors Compensation Plan"

Form 4 regulatory

"This Form 4 reports an equity grant to a Crocs director"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Crocs (CROX) director Beth J. Kaplan report in this Form 4?

Beth J. Kaplan reported receiving 1,252 shares of Crocs common stock as an equity grant. The award was part of her non-employee director compensation and increased her directly held stake to 14,374 shares, with no shares sold or disposed of in this filing.

Was the Crocs (CROX) Beth J. Kaplan transaction a stock purchase or a grant?

The transaction was a stock grant, not an open-market purchase. Kaplan received 1,252 shares at a stated price of $0.0000 per share, reflecting an annual equity award under Crocs’ Board of Directors Compensation Plan for non-employee directors.

How many Crocs (CROX) shares does Beth J. Kaplan hold after this Form 4?

After the reported grant, Beth J. Kaplan directly holds 14,374 shares of Crocs common stock. This total includes the 1,252 shares granted as part of her annual non-employee director compensation, with no derivative securities or additional transactions disclosed in this filing.

What is the purpose of the 1,252-share Crocs (CROX) grant to Beth J. Kaplan?

The 1,252-share grant represents the annual common stock award to Crocs’ non-employee directors. A footnote states it is made under the Board of Directors Compensation Plan, indicating it is routine equity compensation for board service, not a discretionary market trade by the director.

Does the Crocs (CROX) Form 4 show any stock sales by Beth J. Kaplan?

No, the Form 4 shows only an acquisition of shares via a grant to Beth J. Kaplan. There are no sale transactions, option exercises, gifts, or tax-withholding dispositions reported, making this a straightforward compensation-related increase in her direct share ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 06:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KAPLAN BETH J

(Last) (First) (Middle)

C/O CROCS, INC.

500 ELDORADO BLVD #5

(Street)

BROOMFIELD COLORADO 80021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Crocs, Inc. [ CROX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A		1,252(1)	A	$0	14,374	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the annual common stock grant to non-employee directors pursuant to the issuer's Board of Directors Compensation Plan.

Remarks:

	/s/Sara Hoverstock, Attorney-in-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)